France· FR:67143895
LIPOSIC 2 mg/g, gel ophtalmique
A medicinal product containing carbomère 980, registered in France by LABORATOIRE CHAUVIN, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CARBOMÈRE 980
- Manufacturer
- LABORATOIRE CHAUVIN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009359310161 tube(s) polyéthylène de 10 gEUR 2.37
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Carbomère 980 in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandVidisicInPharm Sp. z o.o.
- SpainLIPOLASIC 2 mg/g GEL OFTALMICOLaboratoire Chauvin
- NetherlandsCarbomeer Medcor één dosis ooggel 2 mg/gMedcor Pharmaceuticals B.V.
- NorwayViscotearsOrifarm AS
- FinlandLiposicDr. Gerhard Mann, Chem.-pharm. Fabrik GmbH
- SwedenViscotears 2 mg/g ÖgongelDr. Gerhard Mann Chem.-pharm. Fabrik GmbH
- IcelandVidisicGerhard Mann Dr., Chem.-pharm. Fabrik GmbH
- IrelandLiposic 2 mg/g eye gelBausch + Lomb Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Carbomer Agepha
- Belgium · Liposic
- Germany · Carbomer Edo, Liposic
- Denmark · Viscotears
- Spain · Lipolasic
- Finland · Viscotears
- United Kingdom (Northern Ireland) · Viscotears, Viscotears Single Dose Unit
- Greece · Liposic, Viscoter
- Ireland · Geltears, Liposic
- Iceland · Vidisic
- Italy · Lipovisc
- Luxembourg · Vidisic Edo, Vidisic®
- Netherlands · Liposic, Vidisic Carbogel
- Norway · Viscotears
- Poland · Vidisic
- Portugal · Liposic
- Sweden · Viscotears
- Slovakia · Vidisic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/23737ad5-ad0d-4bcf-bd7f-59593cc0fe06 GET /v1/drugs/23737ad5-ad0d-4bcf-bd7f-59593cc0fe06?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67143895",
"date_amm": "2002-07-03",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "CARBOMÈRE 980",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gel",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about carbomère 980.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.